Platform-based Mild Cognitive Impairment (MCI) Trial

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

December 14, 2021

Study Completion Date

December 14, 2021

Conditions
Mild Cognitive Impairment
Interventions
BEHAVIORAL

Planning for the Future

This intervention will include attending an advance directives meeting, a living arrangements workshop, and a psychosocial education training workshop.

BEHAVIORAL

Enhanced Medical Engagement

This intervention includes creating a health portfolio, health record access training, and a medical engagement workshop

BEHAVIORAL

Confidence Building and Social Engagement

This intervention includes mindfulness training, a pre-experience training techniques workshop and a memory strategies class.

BEHAVIORAL

Physical Intervention

This intervention includes physical/occupational therapy (PT/OT), a home safety assessment, and an independent exercise program.

BEHAVIORAL

Medical Adherence

This intervention includes using automated pillboxes to ensure medication compliance, optimizing appropriate medication use through review, and engaging with memory medications via class.

Trial Locations (1)

40536

University of Kentucky, Lexington

All Listed Sponsors
lead

Allison Gibson

OTHER

NCT03987464 - Platform-based Mild Cognitive Impairment (MCI) Trial | Biotech Hunter | Biotech Hunter